Viewing StudyNCT00060203



Ignite Creation Date: 2024-05-05 @ 11:31 AM
Last Modification Date: 2024-10-26 @ 9:08 AM
Study NCT ID: NCT00060203
Status: COMPLETED
Last Update Posted: 2014-01-16
First Post: 2003-05-06

Brief Title: Brostallicin in Treating Patients With Recurrent or Refractory Multiple Myeloma
Sponsor: Case Comprehensive Cancer Center
Organization: Case Comprehensive Cancer Center

Conditions & Keywords Data

Conditions:
Name
Multiple Myeloma and Plasma Cell Neoplasm
Keywords:
Name View
refractory multiple myeloma View
stage III multiple myeloma View